ARENA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.041
EU - Europa 448
AS - Asia 88
AF - Africa 6
SA - Sud America 4
Totale 1.587
Nazione #
US - Stati Uniti d'America 1.032
IT - Italia 290
IN - India 35
FI - Finlandia 26
CN - Cina 23
BG - Bulgaria 20
SG - Singapore 20
SE - Svezia 19
IE - Irlanda 17
ES - Italia 12
DE - Germania 9
CA - Canada 8
FR - Francia 8
GB - Regno Unito 7
NL - Olanda 6
BE - Belgio 5
CH - Svizzera 5
GR - Grecia 5
TG - Togo 4
UA - Ucraina 4
AT - Austria 3
CL - Cile 3
CY - Cipro 3
JP - Giappone 3
PL - Polonia 3
RU - Federazione Russa 3
HR - Croazia 2
ZA - Sudafrica 2
AR - Argentina 1
BY - Bielorussia 1
EE - Estonia 1
GL - Groenlandia 1
HU - Ungheria 1
ID - Indonesia 1
KR - Corea 1
RO - Romania 1
TH - Thailandia 1
VN - Vietnam 1
Totale 1.587
Città #
Fairfield 168
Rome 148
Chandler 90
Ashburn 86
Woodbridge 77
Seattle 70
Cambridge 57
Wilmington 52
Houston 49
Ann Arbor 30
New York 27
Princeton 27
Helsinki 20
Sofia 20
San Paolo di Civitate 18
Dublin 16
Lawrence 16
Millbury 15
Menlo Park 14
Dearborn 13
San Diego 13
Fasano 11
Plano 11
Barcelona 10
Boston 10
Beijing 9
Chicago 8
Milan 8
Andover 6
Cagliari 6
Los Angeles 6
Athens 5
Brussels 5
Singapore 5
Bremen 4
Lomé 4
Norwalk 4
Sacramento 4
Shanghai 4
Toronto 4
Altavilla Vicentina 3
Bathinda 3
Casale Monferrato 3
Cernobbio 3
Edinburgh 3
Fiumicino 3
Gainesville 3
Limassol 3
Paris 3
Trento 3
Vienna 3
Anguillara 2
Aprilia 2
Aubusson 2
Bern 2
Boscoreale 2
Bovisio-Masciago 2
Falls Church 2
Frankfurt am Main 2
Geneva 2
Guangzhou 2
Johannesburg 2
Kilburn 2
Montreal 2
Nanjing 2
Ottawa 2
Phoenix 2
Redwood City 2
San Mateo 2
Ueuchi 2
Warsaw 2
Washington 2
Zhengzhou 2
Abbiategrasso 1
Aksay 1
Amsterdam 1
Atlanta 1
Bangkok 1
Budapest 1
Bühl 1
Campobasso 1
Carrollton 1
Catania 1
Charlotte 1
Ciampino 1
Federal 1
Florence 1
Fremont 1
Gostyn 1
Hangzhou 1
Hanoi 1
Jakarta 1
Leawood 1
London 1
Málaga 1
Nanchang 1
New Orleans 1
Noisy-le-grand 1
Nuremberg 1
Nuuk 1
Totale 1.254
Nome #
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity 135
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 117
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome 107
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome 98
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome 96
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype 95
Impairment of biliverdin reductase-a promotes brain insulin resistance in Alzheimer disease: a new paradigm 94
Bach1 overexpression in down syndrome correlates with the alteration of the ho-1/bvr-a system: insights for transition to Alzheimer's disease 93
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma 81
Disturbance of redox homeostasis in down syndrome: role of iron dysmetabolism 81
Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology 76
Crosstalk between oxidative stress and inflammation in Alzheimer-like dementia 56
VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor 50
DNA damage triggers an interplay between wtp53 and c-Myc affecting lymphoma cell proliferation and Kaposi sarcoma herpesvirus replication 49
Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases 47
Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53 43
p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53 42
Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells 40
The dysregulation of autophagy and ER stress induced by HHV-6A infection activates pro-inflammatory pathways and promotes the release of inflammatory cytokines and cathepsin S by CNS cells 40
The impairment of DDR reduces XBP1s, further increasing DNA damage, and triggers autophagy via PERK/eIF2alpha in MM and IRE1alpha/JNK1/2 in PEL cells 40
Role of upr sensor activation in cell death–survival decision of colon cancer cells stressed by dpe treatment 38
p62/SQSTM1 promotes mitophagy and activates the NRF2-mediated antioxidant and anti-inflammatory response restraining EBV-driven B lymphocyte proliferation 36
New insights into curcumin-and resveratrol-mediated anti-cancer effects 31
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP. A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas 24
ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress 16
EBV infection of primary colonic epithelial cells causes inflammation, DDR and autophagy dysregulation, effects that may predispose to IBD and carcinogenesis 14
c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway 12
NFE2L2 and STAT3 converge on common targets to promote survival of primary lymphoma cells 12
HSP110 Inhibition in Primary Effusion Lymphoma Cells. One Molecule, Many Pro-Survival Targets 11
The inhibition of IRE1alpha/XBP1 axis prevents EBV-driven lymphomagenesis in NSG mice 10
NRF2 and STAT3: friends or foes in carcinogenesis? 7
HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells 4
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms 3
Acetylation increases expression, interaction with TRAPPC4 and surface localization of PD-L1 2
Totale 1.700
Categoria #
all - tutte 4.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201990 0 0 0 0 0 0 0 0 0 0 47 43
2019/2020286 33 8 4 26 36 37 43 30 32 17 12 8
2020/2021196 6 8 3 12 3 3 8 9 13 102 23 6
2021/2022339 12 11 14 7 23 23 8 34 16 22 92 77
2022/2023371 49 52 7 38 55 31 7 30 40 2 45 15
2023/2024298 23 24 9 19 33 62 27 48 12 41 0 0
Totale 1.700